Insider Transactions in Q3 2025 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 30
2025
|
Kimberly J Popovits |
BUY
Exercise of conversion of derivative security
|
Direct |
64,508
+31.78%
|
$774,096
$12.92 P/Share
|
|
Jul 15
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
752
+1.48%
|
$11,280
$15.63 P/Share
|
|
Jul 15
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
495
+1.48%
|
$7,425
$15.63 P/Share
|
|
Jul 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
18,900
-27.77%
|
$529,200
$28.72 P/Share
|
|
Jul 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+8.72%
|
$52,000
$8.83 P/Share
|
|
Jul 01
2025
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
1,101
+5.62%
|
-
|